Skip to main content

Table 1 Summary of clinical and pathologic information in soft tissue sarcoma.

From: Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets

Total No. affected individual

14

Age (mean ± S.D. (range))

53 ± 30 (23–75)

Gender

 Female

5 (35.7%)

 Male

9 (64.3%)

Tumor size

 0-5 cm

5 (35.7%)

 5-10 cm

6 (42.9%)

 10-15 cm

3 (21.4%)

Grade (FNCLCC)

 I

1 (7.1%)

 II

4 (28.6%)

 III

9 (64.3%)

Primary site

 Upper extremity

2 (14.3%)

 Lower leg

2 (14.3%)

 Thigh

9 (64.3%)

 Pelvis

1 (7.1%)

Stage at time of sample procurement

 Primary

9 (64.3%)

 Local recurrence

3 (21.4%)

 Distant recurrence

2 (14.3%)

Histology

 Myxofibrosarcoma

3 (21.4%)

 Leiomyosarcoma

5 (35.7%)

 Undifferentiated sarcoma

6 (42.9%)

 Undifferentiated pleomorphic sarcoma

4 (28.6%)

 Undifferentiated round cell sarcoma

1 (7.1%)

 Undifferentiated spindle cell sarcoma

1 (7.1%)

Pre-operative Therapy

 None

11 (78.6%)

 Pre-operative Chemotherapy

2 (14.3%)

 Pre-operative Radiation-Therapy

0 (0.0%)

 Both

1 (7.1%)

 Median follow-up

42.29 months

Time to relapse

 Local recurrence

2.0 months

 Distant recurrence

6.1 months